摘要
目的建立同时测定人血浆中抗癫痫药物磷苯妥英(FOS)、苯妥英(PHT)及其主要代谢产物4′-羟苯妥英(4′-HPPH)浓度的高效液相色谱法。方法以盐酸普萘洛尔为内标,血浆样品100μL经20%磷酸酸化后以乙酸乙酯1 mL萃取,提取后氮气吹干,加入流动相100μL复溶,取20μL进样测定。色谱柱采用Agilent RX-C8柱(4.6 mm×250 mm,5μm),柱温:40℃;流动相为甲醇-乙腈-0.1%三氟乙酸水溶液(23∶17∶60),流速为1.5 mL·min-1,紫外检测波长210nm。结果血浆内源性杂质和常用合并用药对样品测定无干扰,色谱峰分离良好。FOS、PHT、4′-HPPH的线性范围分别是1~400,0.5~50和0.5~10 mg·L-1,相关系数(r)均大于0.999 1。平均方法回收率为92.79%~107.90%。各组分的日内、日间RSD均小于8%。结论该方法具有良好的准确性、精密性和灵敏性,且操作快速、简便,各组分之间分离良好,适用于临床血药浓度的监测。
Abstract
OBJECTIVE To develop a simple reversed-phase high-performance liquid chromatography(HPLC) method for thesimultaneous determination of the antiepileptic drugs(AEDs) phenytoin(PHT),its prodrug fosphenytoin(FOS),and its metabolite 4′-hydroxyphenytoin(4′-HPPH) in human plasma.METHODS Plasma sample(100 μL) pre-treatment involved acidification with 20% phosphoric acid,simple extraction with 1 mL of acetic ester containing 10 mg·L-1 propranolol hydrochloride as internal standard and evaporation of solvent,followed by injection of reconstituted sample onto a Agilent RX-C8 column(4.6 mm × 250 mm,5 μm).The mobile phase consisted of methanol-acetonitrile-0.1% triflouroacetic acid(23∶17∶60),and delivered at a 1.5 mL·min-1.The analytes were detected at the wavelength of 210 nm.RESULTS The method was found to be linear over the concentration ranges investigated,1-400 mg·L-1 for FOS,0.5-50 mg·L-1 for PHT and 0.5-10 mg·L-1 for 4′-HPPH,respectively.The intra-and inter-day reproducibility was good with the RSD of 8% or below and relative recovery was ranged from 92.79% to 107.90% for all analytes.CONCLUSION This method was proved to be accurate,sensitive and convenient and suitable for clinical therapeutic drug monitoring.
关键词
磷苯妥英 /
苯妥英 /
4′-羟苯妥英 /
高效液相色谱法
{{custom_keyword}} /
Key words
fosphenytoin /
phenytoin /
4′-hydroxyphenytoin /
HPLC
{{custom_keyword}} /
马春来;焦正;应寅清;施孝金.
反相高效液相色谱法同时测定人血浆中磷苯妥英、苯妥英及其主要代谢产物4′-羟苯妥英的浓度[J]. 中国药学杂志, 2008, 43(22): 1743-1746
M Chun-li;JIO Zheng;YING Yin-qing;SHI Xio-Jin.
Simultaneous Rapid Separation and Determination of Fosphenytoin,Phenytoin and Their Main Metabolite 4′-Hydroxyphenytoin in Human Plasma Using Reversed-Phase HPLC [J]. Chinese Pharmaceutical Journal, 2008, 43(22): 1743-1746
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] BOUCHER B A,FELER C A,DEAN J C, et al. The safety,tolerability,and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients[J] . Pharmacotherapy,1996,16(4):638-645.
[2] CWIK M J,LIANG M,DEYO K,et al. Simultaneous rapid high-performance liquid chromatographic determination of phenytoin and its prodrug,fosphenytoin in human plasma and ultrafiltrate[J] . J Chromatogr B Biomed Sci Appl,1997,693(2):407-414.
[3] KUGLER A R,ANNESLEY T M,NORDBLOM G D,et al. Cross-reactivity of fosphenytoin in two human plasma phenytoin immunoassays[J] . Clin Chem,1998,44(7):1474-1480.
[4] ROBERTS W L,DE B K,COLEMAN J P,et al. Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin[J] . Clin Chem,1999,45(6 Pt 1):829-837.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}